Lion Point Capital »

Aadi Bioscience shares owned by Lion Point Capital

Quarter-by-quarter ownership of Aadi Bioscience (AADI) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Aadi Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Aadi Bioscience held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aadi Bioscience by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $167k 82k 2.02
2023-09-30 $399k 82k 4.84
2023-06-30 $564k 82k 6.84

More positions owned by Lion Point Capital

Semtech Corporation (SMTC)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Marinus Pharmaceuticals Com New (MRNS)
Ardelyx (ARDX)
Milestone Pharmaceuticals (MIST)
Harpoon Therapeutics Com New
Burgerfi International (BFI)
Kiniksa Pharmaceuticals Com Cl A (KNSA)
Insmed Com Par $.01 (INSM)
Battalion Oil Corp (BATL)
Cymabay Therapeutics
Fennec Pharmaceuticals (FENC)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Enphys Acquisition Corp Cl A Ord Shs (NFYS)
Syndax Pharmaceuticals (SNDX)

View all positions for Lion Point Capital

Top funds holding Aadi Bioscience

venBio Select Advisor
Satter Management
Vanguard Group
Decheng Capital
Vivo Capital
Citadel Advisors
Baker Bros. Advisors
683 Capital Management
Lion Point Capital
Squarepoint Ops
Charles Schwab Investment Management
Bank of New York Mellon
Schonfeld Strategic Advisors
Dimensional Fund Advisors
Bank of America Corporation

View all funds holding Aadi Bioscience